Immune System
Modulation of Hematopoietic Stem Cell Composition Holds Promise for Immune System Revitalization
2024-04-03
Japan’s Shionogi Grants US Company the Rights to Develop a Repurposed Allergic Rhinitis Drug as a COVID-19 Cure
2021-01-29
Abbvie Places $2 Billion Bet on Flourishing Immunotherapy Area with this Oncology Partnership
2020-09-06
BioNTech to Test mRNA-Based Cancer Vaccine with Regeneron’s anti-PD1 Drug in Melanoma Patients
2020-08-04
BIO Asia-Taiwan 2020: Nobel Laureate Prof. Tasuku Honjo Reflects on the Future of Cancer Immunotherapy
2020-07-22Partner
LATEST
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115